A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S5G4T-1 in the Treatment of Papulopustular Rosacea
Phase of Trial: Phase III
Latest Information Update: 25 Sep 2018
At a glance
- Drugs Benzoyl peroxide (Primary)
- Indications Rosacea
- Focus Registrational; Therapeutic Use
- Sponsors Sol-Gel Technologies
- 25 Sep 2018 According to a Sol-Gel Technologies media release, the company has completed the 50% enrollment in this Epsolay Program for Papulopustular Rosacea, which consist of two pivotal studies ( SGT54-01 and SGT54-02 ) .
- 04 Sep 2018 Status changed from not yet recruiting to recruiting.
- 22 Jun 2018 New trial record